Pharmacokinetic comparison between quercetin and quercetin 3-O-β-glucuronide in rats by UHPLC-MS/MS. - Wikidata - awgldk - TriplyDB

Pharmacokinetic comparison between quercetin and quercetin 3-O-β-glucuronide in rats by UHPLC-MS/MS.

Pharmacokinetic comparison between quercetin and quercetin 3-O-β-glucuronide in rats by UHPLC-MS/MS.

http://www.wikidata.org/entity/Q37360109

about

Metabolic profiling of quercetin in rats using ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry.Pharmacokinetic Evaluation of Empagliflozin in Healthy Egyptian Volunteers Using LC-MS/MS and Comparison with Other Ethnic Populations

P2860

Q36384660-35C58609-E6F2-428D-9BD4-1D477D7FBC82 Q42234492-BAA022EC-4673-43A5-87A4-698896A8C8A9

P2860

Pharmacokinetic comparison between quercetin and quercetin 3-O-β-glucuronide in rats by UHPLC-MS/MS.

http://www.wikidata.org/entity/Q37360109

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacokinetic comparison bet ...... ronide in rats by UHPLC-MS/MS.

@en

Pharmacokinetic comparison bet ...... ronide in rats by UHPLC-MS/MS.

@nl

type

label

Pharmacokinetic comparison bet ...... ronide in rats by UHPLC-MS/MS.

@en

Pharmacokinetic comparison bet ...... ronide in rats by UHPLC-MS/MS.

@nl

prefLabel

Pharmacokinetic comparison bet ...... ronide in rats by UHPLC-MS/MS.

@en

Pharmacokinetic comparison bet ...... ronide in rats by UHPLC-MS/MS.

@nl

P1433

Q37360109-FC67F4BC-3A5A-4A00-9FAB-33F6E07E035F

P1476

Q37360109-55ED75F7-6626-40FA-914A-E2331B9A2199

P2093

Q37360109-21CF4FAF-77ED-4335-9929-FEB4581E74FC

Q37360109-2B14437A-96B8-4C95-84A3-A72AE6021580

Q37360109-2CFA0131-87BE-4C7B-AFF9-D181DEC5794E

Q37360109-3342DE51-AA3B-46CB-8C1C-6CC4A322A4DC

Q37360109-6030AA21-FCE0-4D94-BC89-BB992162E721

Q37360109-7AFC18D4-1474-4F55-9996-6B6553CDA6E6

Q37360109-DA3A93B2-71E3-457E-B425-A0E6F7DCB55D

Q37360109-F8F10AB2-7961-4992-98D1-2E22A586D3A2

P2860

Q37360109-1174487F-B6E5-4099-A41B-14EF1DF278E9

Q37360109-15D3A733-15DC-465B-BFA4-C0A3A2CE6390

Q37360109-269F260E-E519-461B-860A-3D7A0D291C78

Q37360109-37E05AFF-382C-4949-BC5E-ABC79434879C

Q37360109-3C1547B4-8847-4155-8003-A4E6F7896548

Q37360109-4732779B-0B65-4937-9BB9-CB7336511748

Q37360109-4DD76F26-B2A6-4A04-B874-E6CA89F89538

Q37360109-5BC5D387-38A7-4E18-98FC-796E470029B9

Q37360109-5FD63682-2259-4F80-A69A-BD83A90139FF

Q37360109-62ACF94A-FAFF-431D-87B7-DD87490DBC51

P2888

Q37360109-1974F65F-5E92-44D1-BBDA-B34485499093

P304

Q37360109-DCA11F4D-83E2-4CD7-8FB7-B5CC3CB98FB1

P31

Q37360109-E1981355-7731-426E-BF35-7BDB34395AF3

P356

Q37360109-74E0C4D0-DB28-4D0F-89FA-A5D26A7CDB6B

P407

Q37360109-1EE9F964-5856-440E-9414-920E6F23A1D7

P478

Q37360109-4CD50335-24E1-47EB-8ABF-F4AD6D160D7E

P50

Q37360109-1F1DCD3D-A8FA-4439-9BAB-D786B65F94CE

P577

Q37360109-D9663FD0-96BB-4512-9667-4EDD3010B5C9

P6179

Q37360109-C0883615-6164-4A46-8D24-EF577CAAE95A

P698

Q37360109-5A5D6C21-20BF-4B59-AEC6-B3207733B895

P932

Q37360109-D55C27CF-5953-4221-B748-90A3A6EA0457

P356

P1433

Scientific Reports

P1476

Pharmacokinetic comparison bet ...... ronide in rats by UHPLC-MS/MS.

@en

P2093

Le-Le Yang

http://www.w3.org/2001/XMLSchema#string

Lian-Wen Qi

http://www.w3.org/2001/XMLSchema#string

Na Xiao

http://www.w3.org/2001/XMLSchema#string

Ping Li

http://www.w3.org/2001/XMLSchema#string

Raphael N Alolga

http://www.w3.org/2001/XMLSchema#string

Shi-Lei Wang

http://www.w3.org/2001/XMLSchema#string

Xiao-Wei Li

http://www.w3.org/2001/XMLSchema#string

Xiao-Yue Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats

Antioxidant properties of flavonol glycosides from green beans.

Identification of quercetin 3-O-beta-D-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin.

How should we assess the effects of exposure to dietary polyphenols in vitro?

Protection by quercetin and quercetin 3-O-beta-D-glucuronide of peroxynitrite-induced antioxidant consumption in human plasma low-density lipoprotein.

The flavonoid quercetin in disease prevention and therapy: facts and fancies.

Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of Nelumbo nucifera, and structure-activity correlations with related alkaloids.

The "French Paradox" and beyond: neuroprotective effects of polyphenols.

Absorption and metabolism of flavonoids.

Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease.

P2888

P304

35460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP35460

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012929884

http://www.w3.org/2001/XMLSchema#string

P698

27775094

http://www.w3.org/2001/XMLSchema#string

P932

5075792

http://www.w3.org/2001/XMLSchema#string